ISRCTN31871098已完成不适用
Randomised placebo-controlled trial of adjuvant therapy with Withania somnifera in Parkinson?s Disease
Higher Education Commission of Pakistan (HEC) (Pakistan)0 个研究点目标入组 30 人开始时间: 2010年6月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients, of either sex, aged 30-65, with mild to moderate Parkinson's Disease
- •2. Levodopa-responsive and participants demonstrate some identifiable 'on response' as observed by investigator
- •3. Participants demonstrate severe motor fluctuations in spite of individually optimized levodopa treatment investigator.
排除标准
- •1. Diagnosis is unclear or a suspicion of other Parkinsonian syndromes. A group of diseases characterised by symptoms (e.g. tremour, rigidity or stiffness, slow movements and difficulty maintaining balance) common in Parkinson's disease like:-
- •1.1. Patients with Parkinson?s Plus syndromes
- •1.2. Essential tremors
- •1.3. Dementia with Lewy bodies
- •1.4. Progressive supranuclear palsy
- •1.5. The syndromes of olivopontocerebellar atrophy
- •1.6. Striatonigral degeneration
- •1.7. Shy-Drager
- •2. Undergone surgery for the treatment of PD
- •3. Contraindications to levodopa, or a condition which makes the treatment inadvisable
- •4. People with any neurological deficit that may interfere with the study assessments
- •5. Any sign of infection any where in the body at the time of assessment
- •6. Pregnant or lactating
研究者
相似试验
尚未招募
2 期
Prospective randomized trial of an adjuvant therapy of completely resected Merkel Cell Carcinoma (MCC) with immune checkpoint blocking antibodies (Nivolumab, Opdivo®; Ipilimumab, Yervoy®) versus observatioNL-OMON50102niversity Hospital Essen30
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlycompletely resected Merkel cell carcinomaMedDRA version: 21.1Level: LLTClassification code 10064025Term: Merkel cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-000043-78-DEniversity of Essen190
进行中（未招募）
1 期
Comparison of therapy of Merkel Cell Carcinoma (MCC) with Ipilimumab (Yervoy®) or Nivolumab (Opdivo®) versus observation onlyEUCTR2013-000043-78-NLniversity of Essen190
进行中（未招募）
不适用
A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer. - BILCAPPartients who have undergone surgical resection of a biliary tract cancer (including intrahepatic and extrahepatic cholangiocarcinoma, cancer of the distal bile duct and muscle invasive gallbladder cancer).EUCTR2005-003318-13-GBThe University of Southampton360
招募中
3 期
a phase 3 study of chemotherapy folowed by surgery and postoperative chemotherapy compared to initial surgery followed by chemotherapy in advanced ovarian cancerCTRI/2014/01/004363Sri Venkateswara Institute of Medical Sciences60